Delivery Order SPE2DB24D1205-SPE2DB24FCSWH
Award Date
7/17/24
Potential Completion Date
7/18/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of RINVOQ ER 30 MG TABLET UU 30S to the Defense Logistics Agency (DLA), a defense agency. The $45,404.89 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 10, 2024 with a completion date of June 11, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a vehicle for providing a...
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $35,250.60, is a Firm Fixed Price Delivery Order with an ultimate completion date of October 18, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
The federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $6,555.96. The contract has an ultimate completion date of November 1, 2024 and is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite...
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The $8,169.67 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 20, 2024 and is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $13,861.26 and an ultimate completion date of June 20, 2024. It is not set aside for any specific business type. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government, including the Department of Defense (DoD) and Veterans Affairs (VA). The contract is a Delivery Order with a Firm Fixed Price of $9,783.30 and an ultimate completion date of June 28, 2024....
This federal contract award is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,020.55 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 3, 2024 with a completion date of June 4, 2024. The contract is a delivery order and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
The federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S pharmaceutical products to the Medical Supply Chain, a defense agency under the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 25, 2023, with a ceiling value of $49,043.84 and an ultimate completion date of October 26, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug...
This federal contract award is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $21,859.56, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 18, 2024. The contract has an ultimate completion date of September 19, 2024 and is a firm fixed-price delivery order. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 11, 2024, with a completion date of June 12, 2024. The contract has a ceiling value of $6,086.64 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp...